We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTCH icon
2476
Match Group
MTCH
$8.55B
$20K ﹤0.01%
282
-6,077
-96% -$474K
NMFC icon
2477
New Mountain Finance
NMFC
$732M
$20K ﹤0.01%
1,455
-405
-22% -$5.52K
OI icon
2478
O-I Glass
OI
$1.08B
$20K ﹤0.01%
1,890
-796
-30% -$10.3K
REI icon
2479
Ring Energy
REI
$339M
$20K ﹤0.01%
12,197
+10,454
+600% +$22.4K
STC icon
2480
Stewart Information Services
STC
$2.08B
$20K ﹤0.01%
+515
New +$19.2K
STNG icon
2481
Scorpio Tankers
STNG
$3.81B
$20K ﹤0.01%
+670
New +$18.4K
TCX icon
2482
Tucows
TCX
$175M
$20K ﹤0.01%
374
+340
+1,000% +$17.7K
WEYS icon
2483
Weyco Group
WEYS
$440M
$20K ﹤0.01%
+886
New +$22.1K
ETRN
2484
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$20K ﹤0.01%
1,375
-787
-36% -$12.1K
DOOR
2485
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$20K ﹤0.01%
347
+155
+81% +$8.23K
ONCT
2486
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$20K ﹤0.01%
200
+142
+245% +$14.5K
APRN
2487
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$20K ﹤0.01%
196
+193
+6,433% +$18.8K
SIOX
2488
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$20K ﹤0.01%
3,237
-984
-23% -$6.79K
NWHM
2489
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$20K ﹤0.01%
4,605
+3,724
+423% +$15.3K
FFG
2490
DELISTED
FBL Financial Group
FFG
$20K ﹤0.01%
340
+314
+1,208% +$18.7K
NEOS
2491
DELISTED
Neos Therapeutics, Inc
NEOS
$20K ﹤0.01%
13,562
+8,062
+147% +$13K
SRCI
2492
DELISTED
SRC Energy Inc
SRCI
$20K ﹤0.01%
4,480
+1,795
+67% +$8.11K
SEMG
2493
DELISTED
SEMGROUP CORPORATION
SEMG
$20K ﹤0.01%
+1,222
New +$14.3K
AMSF icon
2494
AMERISAFE
AMSF
$540M
$19K ﹤0.01%
+282
New +$18.7K
CC icon
2495
Chemours
CC
$2.37B
$19K ﹤0.01%
1,278
-13,559
-91% -$221K
CIVI
2496
DELISTED
Civitas Resources
CIVI
$19K ﹤0.01%
+847
New +$18.8K
CORT icon
2497
Corcept Therapeutics
CORT
$12B
$19K ﹤0.01%
1,372
+693
+102% +$8.52K
CVGW
2498
DELISTED
Calavo Growers
CVGW
$19K ﹤0.01%
199
-49
-20% -$4.5K
CWBC
2499
Community West Bancshares
CWBC
$684M
$19K ﹤0.01%
+915
New +$18.7K
DOCU
2500
DocuSign
DOCU
$11.5B
$19K ﹤0.01%
307
-2,842
-90% -$149K

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.